Research Paper Volume 17, Issue 2 pp 588—606
Pan-cancer analysis of Methyltransferase-like 16 (METTL16) and validated in colorectal cancer
Figure 3. Mutation status of METTL16 across TCGA tumors. (A) The alteration frequency with mutation type. (B) Mutation site (C) The association between mutation and OS (Overall survival), PFS (Progression-free survival) and DSS (Disease-specific survival). (D) A Spearman association between METTL16 CNV and mRNA was performed in pan-cancer.